GSK Pharma Q2 profit down 23 Percent to Rs 101 crore

Written by Medical Dialogues Bureau Published On 2018-10-23T10:03:29+05:30 | Updated On 23 Oct 2018 10:03 AM IST

GSK Pharma Q2 profit down 23 Percent to Rs 101 crore

New Delhi: GlaxoSmithKline(GSK)Pharmaceuticals has reported 22.67 per cent fall in standalone net profit to Rs 100.77 crore for the quarter ended September 30, 2018. The company had posted a net profit of Rs 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.

Total income of the company stood at Rs 831.13 crore for the reported quarter. It was Rs 845.89 crore in the second quarter of 2017-18.

GlaxoSmithKlineGSK PharmaRs 101 crore

Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Medical Dialogues Bureau

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here